Rizwana Zaman

Dr. Rizwana Zaman

Georgia Cancer Center, Augusta University, Augusta, Georgia, USA
orcid
Research Associate

Research Focus & Metrics

Academic Career Length

6Years (2021-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
Verified
Journal Article
Open access
PDF file
MEMahmoud Elashiry
Mahmoud Elashiry
CTCeline Joyce Cornelius Timothius
Celine Joyce Cornelius Timothius
Rizwana ZamanRizwana Zaman
Rizwana Zaman
MEMarisa Elliott
Marisa Elliott
BCBryce Crosby
Bryce Crosby
RERanya Elsayed
Ranya Elsayed
Cellular senescence is a fundamental biological process characterized by stable cell cycle arrest, resistance to apoptosis, and the acquisition of a pro-inflammatory senescence-associated secretory phenotype (SASP). While senescence plays essential roles in development, tissue homeostasis, and tumor suppression, its accumulation with age and chronic stress contributes to tissue dysfunction and disease. In the oral cavity, where tissues are continuously exposed to mechanical stress, microbial challenge, and environmental insults, senescence has emerged as a critical regulator of both health and pathology. This review provides an overview of the defining hallmarks of cellular senescence, the molecular mechanisms driving its onset, and its physiological and pathological consequences, with a particular focus on oral tissues. We highlight the beneficial roles of senescence in maintaining oral tissue integrity, facilitating wound repair, suppressing malignant transformation, and promoting immune-mediated clearance of damaged cells. Conversely, we discuss the detrimental effects of persistent senescent cell accumulation, including oral aging phenotypes, chronic inflammation, alveolar bone loss, periodontal breakdown, salivary gland dysfunction, and contributions to oral carcinogenesis. Finally, we examine emerging therapeutic strategies targeting senescence in oral disease management, including senolytic and senomorphic approaches, immune-based clearance mechanisms, and gene- and cell-based interventions aimed at delaying or modulating senescence. Understanding the dualistic nature of cellular senescence in the oral environment may inform novel preventive and therapeutic strategies to promote oral health and mitigate age- and disease-associated oral pathologies.

27 November 2023 in Clinical Case Reports
Verified
Journal Article
Open access
KHKakali Halder
Kakali Halder
NTNusrat Noor Tanni
Nusrat Noor Tanni
RKRubaiya Binte Kabir
Rubaiya Binte Kabir
MNMaherun Nesa
Maherun Nesa
MRMd. Faizur Rahman
Md. Faizur Rahman
SSS.M Shamsuzzaman
S.M Shamsuzzaman
Key Clinical Message: The incidence of nontuberculous mycobacterial (NTM) infections after operations is increasing in Bangladesh but data regarding clinical presentation, diagnosis, treatment, and prognosis after treatment are lacking. In this case series, three patients having persistent serous discharge from incision wound after operation were studied. Discharge from wounds were collected, wet film microscopy was performed for pus cells and fungus, Gram stain, Ziehl‐Neelsen (ZN) stain, culture in routine culture media and Lowenstein‐Jensen (LJ) media, Xene‐Xpert for mycobacterium tuberculosis (MTB), polymerase chain reaction (PCR) for NTM were done. NTM‐positive patients were treated initially for 6 weeks with four drugs regimen (clarithromycin 500 mg 12 hourly, ciprofloxacin 500 mg 12 hourly, linezolid 400 mg 12 hourly, and amikacin 500 mg 12 hourly), followed by 5 months with three drugs regimen (clarithromycin 500 mg 12 hourly, ciprofloxacin 500 mg 12 hourly, and linezolid 400 mg 12 hourly) as a maintenance dose. Cessation of discharge occurred within 3–4 weeks after starting treatment, and the wounds were healed.

1 January 2021 in SSRN Electronic Journal
Verified
Preprint
Open access
PDF file
NTNusrat Noor Tanni
Nusrat Noor Tanni
MNMaherun Nesa
Maherun Nesa
RKRubaiya Binte Kabir
Rubaiya Binte Kabir
FHFarjana Binte Habib
Farjana Binte Habib
Rizwana ZamanRizwana Zaman
Rizwana Zaman
SSS. M. Shamsuzzaman
S. M. Shamsuzzaman
Background: Oxford AstraZeneca (Covishield) vaccine is the 1st vaccine administered in Bangladesh to prevent the spread of severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2). We assessed the antibody response after 1st and 2nd dose of this vaccine in health care workers of Dhaka Medical College hospital, Bangladesh. Methods: Health care workers (teachers, clinicians and medical staff) of Dhaka Medical College Hospital who participated in this study were asked to collect blood sample after 28 days of 1st vaccination and 14 days after 2nd vaccination. Quantitative post-vaccination antibody responses were measured using the chemiluminescent immunoassay, ADVIA Centaur (Siemens, Munich, Germany) SARS-CoV-2 IgG (COV2G) assay (output index was ≥1·00). Findings: Among 308 participants 197(64%) were male and 111(36%) were female. The mean age was 45·08 years (±9·2 years). 35·06% participants were previously COVID-19 positive confirmed by RT- PCR. Vaccine related antibody was found in 126(41%) participants after 1st dose of AstraZeneca vaccine. After 2nd dose of vaccine reactive level of antibody was found in 172(93%) participants. Antibody responses were significantly higher in previously infected participants compared to participants who had no history of previous COVID-19 after1st dose (51·92±50·85 vs 23·67±41·07, p=0·001) as well as 2nd dose of vaccine (64·12±97·76 vs 35·04±64·84, p=0·001). No difference in antibody response was observed among participants with or without comorbidities. Interpretation: Oxford AstraZeneca Covishield vaccine induces a strong immune response after two doses of vaccination. Funding Information: The study was funded by the office of Directorate General of Health Services, Ministry of Health and Family Welfare, Bangladesh. Declaration of Interests: We wish to confirm that there are no known conflicts of interest associated with this publication. Ethics Approval Statement: All the participants provided written informed consent and the protocol was approved by ethical review committee of Dhaka Medical College.

1 January 2021 in Archives of Microbiology & Immunology
Verified
Journal Article
Open access
PDF file
Rizwana ZamanRizwana Zaman
Rizwana Zaman
SSS.M. Shamsuzzaman
S.M. Shamsuzzaman
Emergence of MDR P. mirabilis is a threat for high morbidity and mortality with catheter-associated urinary tract infections leading to urolithiasis and permanent renal damage, bacteremia and sepsis. Global shortage of new effective antibiotic with reduced susceptibility of P. mirabilis to imipenem, tigecycline and resistance to colistin needs antimicrobial combinations. So, different antimicrobial combinations were used to see their efficacy both in vitro and in vivo with their resistance in Bangladesh. MIC of antibiotics alone and in combination and efficacies of different antibiotic combinations in vivo (mice model) were evaluated. PCR and sequencing of resistance genes were done. Among the 500 samples, 70% were culture positive and out of these, 10.57% were P. mirabilis. Among isolated P. mirabilis, 24.32%, 21.62%, 27.03% and 78.38% were resistant to fosfomycin, imipenem, tigecycline and amikacin respectively and 75.68%, 13.51% and 10.81% were MDR, XDR and PDR respectively. Among fosfomycin resistant P. mirabilis, 77.78%, 44.44% and 22.22% were positive for fosA, fosA3 and fosA4 respectively. Among imipenem resistant P. mirabilis, 62.50% were positive for NDM-1 and OXA-10, 50% for NDM-2, OXA-23 and OXA-48, 25% for OXA-58. In vitro combination of imipenem-amikacin and imipenem-fosfomycin showed 100%, and 75% synergism respectively. The best in vivo results appeared in the group treated with imipenem-amikacin and imipenem-fosfomycin combinations where 100% bacterial clearance was observed. As P. mirabilis showed high level resistance towards commonly used antimicrobial agents, it is very difficult to treat by a single agent. So, emphasis should be given on using antibiotic combinations.

1 January 2023 in Archives of Microbiology & Immunology
Verified
Journal Article
Open access
PDF file
AHAzmeri Haque
Azmeri Haque
NMNafisa Jabin Mishu
Nafisa Jabin Mishu
HKH M Khaleduzzaman
H M Khaleduzzaman
SSS M Shamsuzzaman
S M Shamsuzzaman
ASAvizit Sarker
Avizit Sarker
Md. AsaduzzamanMd. Asaduzzaman
Md. Asaduzzaman
Emergence of multidrug resistant strains of Enterobacter spp. has a potential threat because these strains were responsible for high morbidity and mortality in recent years due to nosocomial infection in health care settings. Due to shortage of new effective antibiotic, old drug like fosfomycin recently reintroduced in human medicine for the treatment of multi drug resistant (MDR) gram negative bacteria. Sample size was 360. We collected different samples like urine, wound swab, endotracheal aspirate and blood from microbiology lab of Dhaka medical college. Organisms were isolated and identified by culture, gram staining and biochemical tests. Further tests were done only on common Enterobacter species. Antibiotic susceptibility tests were performed by disc diffusion technique. Polymerase chain reaction (PCR) was used to identify different colistin resistance genes (mcr-1 and mcr-2,) fosfomycin resistance genes (fosA, fosA3, fosA4) and carbapenem resistance genes (blaKPC, blaIMP, blaVIM and blaOXA-48 / blaOXA181). Sequencing of fosA4 gene was done. Present study observed the presence of fosfomycin resistance gene of multidrug resistant (MDR) Enterobacter spp. Among the 360 samples 66.11% yielded culture positive results and out of the culture positive samples 10.53% were Enterobacter spp. Among Enterobacter spp. 82.76% E. cloacae and 17.24% E. aerogenes were identified by biochemical tests. Among the 17.24% isolated E. aerogenes, 100% were resistant to amoxiclav and cefoxitin and ceftazidime, 80% were resistant to ciprofloxacin and amikacin, 60% were resistant to piperaicillin-tazobactam, cefuroxime and ceftriaxone, 40% were resistant to aztreonum, cefepime and fosfomycin, 20% were resistant to imipenem and colistin but none were resistant to tigecycline. Among the fosfomycin resistant Enterobacter spp. 80% were positive for fosA gene, 50% were positive for fosA4 gene, 50% were positive for fosA5gene. Sequencing of PCR product of fosA4 gene showed multiple point mutations. So, Antimicrobial susceptibility testing must be done before prescribing antibiotics due to the high rates of resistance of Enterobacter spp. to multiple antibiotics.

17 July 2022
Verified
Journal Article
Closed access
MNMaherun Nesa
Maherun Nesa
RKRubaiya Binte Kabir
Rubaiya Binte Kabir
FHFarjana Binte Habib
Farjana Binte Habib
Rizwana ZamanRizwana Zaman
Rizwana Zaman
NTNoor-E-Jannat Tania
Noor-E-Jannat Tania
SSS. M. Shamsuzzaman
S. M. Shamsuzzaman